25 results
S-4
EX-99.1
CHRS
Coherus Biosciences Inc
7 Jul 23
Registration of securities issued in business combination transactions
5:03pm
are experts with respect to any part of such Registration Statement within the meaning of the term “expert” as used in, or that we come within
8-K
EX-99.1
CHRS
Coherus Biosciences Inc
14 May 18
Departure of Directors or Certain Officers
5:22pm
and payer expert of Dr. Nussbaum’s stature join the Coherus Board of Directors. Recent introductions of therapeutic biologics and biosimilars
8-K
EX-99.1
CHRS
Coherus Biosciences Inc
10 Apr 17
Departure of Directors or Certain Officers
12:00am
by the Arbitrator on a showing of substantial need, either party may: (1) designate one expert witness; (2) take the deposition of one individual and the other … party’s expert witness; (3) propound requests for production of documents; and (4) subpoena witnesses and documents relating to the discovery
DRS/A
EX-10
p032 q1ddbm
5 Aug 14
Draft registration statement (amended)
12:00am
DRS/A
EX-10
sidf3
5 Aug 14
Draft registration statement (amended)
12:00am
8-K
EX-2.1
zunjby813 942abh
22 Jan 24
Coherus Announces Agreement to Divest Ophthalmology Franchise to Sandoz in Conference Call Information
8:01am
S-4/A
j4aqg0nsh9j9cc79
24 Jul 23
Registration of securities issued in business combination transactions (amended)
4:42pm
S-4
a3qu6
7 Jul 23
Registration of securities issued in business combination transactions
5:03pm
424B3
kfg3zrpxwsxbdp5iv6l3
26 Jul 23
Prospectus supplement
4:59pm
10-K
a0k8hij0ittcfyzdom
23 Mar 15
Annual report
12:00am